Editor's Note This study, led by researchers at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, finds that despite the challenges associated with COVID-19, many US hospital systems were able to implement strategies in keeping with time-to-surgery standards for orthopedic trauma patients. Of 3,589 patients from 20 sites in the US and…

Read More

Editor's Note This study from the Massachusetts Institute of Technology, Cambridge, and Massachusetts Eye and Ear, Boston, finds that the SARS-CoV-2 virus can infect cells of the inner ear, including hair cells, which are critical for hearing and balance. A series of 10 COVID-19 patients with audiovestibular symptoms, such as…

Read More

Editor's Note In FY 2022, the Centers for Medicare and Medicaid Services (CMS) will penalize 2,499 (47%) hospitals for excessive patient readmissions, the October 28 Kaiser Health News reports. In its 10th year of the Hospital Readmissions Reduction Program, CMS will cut payments to the penalized hospitals by as much…

Read More

Editor's Note This study from the Massachusetts General Hospital and Harvard Medical School, Boston, finds that the transition to incorporate virtual care into ambulatory healthcare during COVID-19 was not associated with an increased overall number of visits. The researchers identified 10,559,857 ambulatory visits by 1,530,772 patients at their large New…

Read More

Editor's Note In this study, researchers at the University of Southern California, Los Angeles, find that overweight and obese adolescents and adults experienced more respiratory symptoms from COVID-19. Of 552 individuals enrolled in the study, 470 tested positive for COVID-19, including 261 adults (18 years or more old), 61 adolescents…

Read More

Editor's Note In an October 26 news release, ECRI announced the publication of a Position Statement on “COVID-19 Vaccines: Mitigating Disease and Promoting Global Health Equity.” Speaking in support of the Statement, Marcus Schabacker, MD, PhD, president and chief executive officer, ECRI, says: “Despite the FDA and CDC’s advancement of…

Read More

Editor's Note This study by researchers at Harvard Medical School, Brigham and Women’s Hospital, and Massachusetts General Hospital, Boston, finds that a high-risk allergy history was associated with a 2.5-fold higher risk of allergic reactions after mRNA COVID-19 vaccinations. However, most of the allergy symptoms did not hold up completion…

Read More

Editor's Note The Centers for Disease Control and Prevention (CDC) director Rochelle P. Walensky, MD, MPH, on October 21, endorsed the CDC Advisory Committee on Immunization Practices’ recommendation for a booster of COVID-19 vaccines in certain populations. For individuals who received Pfizer-BioNTech or Moderna COVID-19 vaccines, the following are eligible…

Read More

  Editor's Note This Israeli study finds that in healthcare workers (HCWs) vaccinated with the Pfizer-BioNTech vaccine who had breakthrough infections, the suspected source was an unvaccinated person. Among 11,453 fully vaccinated HCWs, 1,497 had RT-PCR testing during the study period. Of the tested HCWs, 39 breakthrough cases were found.…

Read More

Editor's Note This study by researchers at Yale University School of Medicine, New Haven, Connecticut, identifies three themes centered on trust and addressing barriers to COVID-19 vaccine access in Black and Latinx communities in the US. The study involved 72 participants—56 women, 16 men, 36 Black, 28 Latinx, and 8…

Read More